Associate Professor Joy Wolfram<\/h1><\/div><\/div><\/div><\/div><\/div><\/div>![\"Associate](\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" "\\"joy-wolfram\\"")
<\/span><\/div><\/div><\/div><\/div>Research Director<\/h2>\nBS, MS, PhD<\/h3>\n
Associate Professor Joy Wolfram leads a research program dedicated to advancing cell and cell-derived therapeutics towards clinical translation. Before joining The University of Queensland, she spent more than a decade in hospital-based research institutes, including leading a research group at Mayo Clinic\u2014ranked the world\u2019s best hospital by Newsweek<\/i>\u2014where she also served as Associate Director of the PhD Program in Regenerative Sciences.<\/p>\n
A\/Prof Wolfram has published more than 100 peer-reviewed papers (h-index 53; >22,000 citations, Google Scholar) in leading journals such as Nature Reviews Materials<\/i> (IF 86.2) and Nature Nanotechnology<\/i> (IF 38.1). She has delivered over 100 keynote and invited presentations, and her research has been featured in 65 international media outlets (Altmetric), including those with a readership of more than 350 million, such as China Daily<\/i>. She also contributes to the boards and scientific advisory panels of several companies with a cumulative customer base of more than 20 million.<\/p>\n
As a named investigator, A\/Prof Wolfram has secured $270 million in research funding. Her laboratory includes clinician-scientists, and she holds an affiliate appointment at Houston Methodist Hospital, ranked among the top 20 hospitals in the United States by U.S. News & World Report<\/i>. She has organised national health consumer workshops and published frameworks to guide consumer\u2013researcher partnerships. As a TED Speaker, she is committed to communicating science clearly and making biomedical innovation accessible to global audiences.<\/p>\n<\/div>
![\"Associate](\"https:\/\/metronorth.health.qld.gov.au\/herston-biofabrication-institute\/wp-content\/uploads\/sites\/16\/2026\/01\/joy-wolfram.png\" "\\"joy-wolfram\\"")
<\/span><\/div>Research Director<\/h2>\nBS, MS, PhD<\/h3>\n
Associate Professor Joy Wolfram leads a research program dedicated to advancing cell and cell-derived therapeutics towards clinical translation. Before joining The University of Queensland, she spent more than a decade in hospital-based research institutes, including leading a research group at Mayo Clinic\u2014ranked the world\u2019s best hospital by Newsweek<\/i>\u2014where she also served as Associate Director of the PhD Program in Regenerative Sciences.<\/p>\n
A\/Prof Wolfram has published more than 100 peer-reviewed papers (h-index 53; >22,000 citations, Google Scholar) in leading journals such as Nature Reviews Materials<\/i> (IF 86.2) and Nature Nanotechnology<\/i> (IF 38.1). She has delivered over 100 keynote and invited presentations, and her research has been featured in 65 international media outlets (Altmetric), including those with a readership of more than 350 million, such as China Daily<\/i>. She also contributes to the boards and scientific advisory panels of several companies with a cumulative customer base of more than 20 million.<\/p>\n
As a named investigator, A\/Prof Wolfram has secured $270 million in research funding. Her laboratory includes clinician-scientists, and she holds an affiliate appointment at Houston Methodist Hospital, ranked among the top 20 hospitals in the United States by U.S. News & World Report<\/i>. She has organised national health consumer workshops and published frameworks to guide consumer\u2013researcher partnerships. As a TED Speaker, she is committed to communicating science clearly and making biomedical innovation accessible to global audiences.<\/p>\n<\/div>